iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 3 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

0
Player Avatar OklaBoston (68.65) Submitted: 12/28/2012 1:29:30 PM : Outperform Start Price: $5.05 ICAD Score: +3.74

A zacks.com "On The Move" stock still under $10 and with a high consistency rating from StockScouter.

Those three things don't all point the same way very often.

Featured Broker Partners


Advertisement